Navigation Links
Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting

VANCOUVER, May 24 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced that June 26, 2008 has been set as the date for the Annual Stockholders Meeting.

The Annual Meeting of Dragon stockholders will be held at Suite 2808, International Chamber of Commerce Tower, Fuhua Three Road, Shenzhen, China at 2:00 p.m. local time. Stockholders of record as of the close of business on May 26, 2008 will be entitled to vote on the election of directors.

On or about May 30, 2008, the Company will send to these stockholders a copy of the proxy statement in connection to the Annual Meeting.

CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, COO, Telephone: (604) 669-8817, or North America Toll Free: 1-877-388-3784, Email:, Website:

SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
2. Dragon Pharma announces 2007 full year financial results
3. Dragon retains leading investor relations firm
4. Dragon announces new product launch; increase in annual production output capacity
5. Dragon Announces R&D Achievement in Biotech Manufacturing Process
6. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
9. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
10. Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry
11. VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors
Post Your Comments:
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
Breaking Biology Technology:
(Date:6/22/2016)... 2016 On Monday, the Department of Homeland ... share solutions for the Biometric Exit Program. The Request ... Protection (CBP), explains that CBP intends to add biometrics ... the United States , in order to deter ... Logo - ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
Breaking Biology News(10 mins):